Michael R. Abern

1.8k total citations · 1 hit paper
46 papers, 1.1k citations indexed

About

Michael R. Abern is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Michael R. Abern has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 14 papers in Surgery. Recurrent topics in Michael R. Abern's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (14 papers) and Global Cancer Incidence and Screening (9 papers). Michael R. Abern is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (14 papers) and Global Cancer Incidence and Screening (9 papers). Michael R. Abern collaborates with scholars based in United States, Sweden and Germany. Michael R. Abern's co-authors include Simone Crivellaro, Hari T. Vigneswaran, Simone Francavilla, Luca Morgantini, Ushasi Naha, Daniel Moreira, Martin Eklund, Stevan Weine, José M. Flores and Ömer Acar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael R. Abern

45 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey

2020 387 citations Luca Morgantini, Ushasi Naha et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Abern United States	18	362	345	282	259	202	46	1.1k
Ömer Acar Türkiye	15	323 0.9×	296 0.9×	287 1.0×	151 0.6×	121 0.6×	92	1.0k
Hari T. Vigneswaran United States	13	280 0.8×	303 0.9×	283 1.0×	429 1.7×	138 0.7×	41	997
Jim Barber United Kingdom	8	412 1.1×	79 0.2×	102 0.4×	175 0.7×	137 0.7×	21	876
Hooyeon Lee South Korea	18	414 1.1×	124 0.4×	93 0.3×	388 1.5×	414 2.0×	67	1.2k
Marlene Camacho‐Rivera United States	16	275 0.8×	203 0.6×	169 0.6×	102 0.4×	325 1.6×	76	1.2k
Katarzyna Szamotulska Poland	20	326 0.9×	167 0.5×	65 0.2×	182 0.7×	121 0.6×	103	1.5k
Andrew Courtwright United States	23	283 0.8×	315 0.9×	146 0.5×	484 1.9×	133 0.7×	104	1.7k
Jacqueline Brown United Kingdom	20	273 0.8×	131 0.4×	147 0.5×	129 0.5×	279 1.4×	50	1.4k
Dana Nickleach United States	23	364 1.0×	434 1.3×	137 0.5×	199 0.8×	267 1.3×	36	1.2k
David B. Samadi United States	22	702 1.9×	191 0.6×	44 0.2×	432 1.7×	166 0.8×	75	1.5k

Countries citing papers authored by Michael R. Abern

Since Specialization

Citations

This map shows the geographic impact of Michael R. Abern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Abern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Abern more than expected).

Fields of papers citing papers by Michael R. Abern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Abern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Abern. The network helps show where Michael R. Abern may publish in the future.

Co-authorship network of co-authors of Michael R. Abern

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Abern. A scholar is included among the top collaborators of Michael R. Abern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Abern. Michael R. Abern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vigneswaran, Hari T., Martin Eklund, Andrea Discacciati, et al.. (2024). Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial.. Journal of Clinical Oncology. 42(4_suppl). 262–262. 3 indexed citations

Vigneswaran, Hari T., et al.. (2023). Biparametric Quantitative MRI for Prostate Cancer Detection. Topics in Magnetic Resonance Imaging. 32(6). 66–72. 2 indexed citations

Leonardo, Trevor R., Michael J. Schlicht, Klara Valyi‐Nagy, et al.. (2023). Prostate‐derived circulating microRNAs add prognostic value to prostate cancer risk calculators. SHILAP Revista de lepidopterología. 2(11). 1 indexed citations

Abern, Michael R., et al.. (2022). Prostate Cancer Disparities in Hispanics Using the National Cancer Database. Urology. 165. 218–226. 6 indexed citations

Vigneswaran, Hari T., Alessio Crippa, Martin Eklund, et al.. (2021). Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 25(2). 165–173. 6 indexed citations

Vigneswaran, Hari T., Jyotsna S. Jagai, David Greenwald, et al.. (2021). Association between environmental quality and prostate cancer stage at diagnosis. Prostate Cancer and Prostatic Diseases. 24(4). 1129–1136. 13 indexed citations

Vigneswaran, Hari T., et al.. (2020). A Comparison of Perioperative Outcomes Between Single-port and Multiport Robot-assisted Laparoscopic Prostatectomy. European Urology. 77(6). 671–674. 68 indexed citations

Morgantini, Luca, Ushasi Naha, Heng Wang, et al.. (2020). Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey. PLoS ONE. 15(9). e0238217–e0238217. 387 indexed citations breakdown →

Naha, Ushasi, Stephen J. Freedland, Michael R. Abern, & Daniel M. Moreira. (2020). The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer. Prostate Cancer and Prostatic Diseases. 24(2). 335–340. 13 indexed citations

10.

Vigneswaran, Hari T., Andrea Discacciati, Peter H. Gann, et al.. (2020). Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort. Prostate Cancer and Prostatic Diseases. 24(1). 120–127. 4 indexed citations

11.

Vigneswaran, Hari T., et al.. (2020). Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US. Annals of Surgical Oncology. 28(5). 2790–2800. 16 indexed citations

12.

Coogan, Christopher L., et al.. (2019). Urology Residents’ Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop. Urology. 134. 51–55. 4 indexed citations

13.

Souza, Rodrigo Pagani de, Samuel Ohlander, Michael R. Abern, et al.. (2019). Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy. Urology. 137. 97–101. 4 indexed citations

14.

Tsivian, Matvey, Michael R. Abern, Christina Sze, et al.. (2018). Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(8). 362.e1–362.e7. 9 indexed citations

15.

Dobbs, Ryan W., Neha Malhotra, Michael R. Abern, & Daniel M. Moreira. (2018). Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis. Prostate Cancer and Prostatic Diseases. 22(1). 159–167. 18 indexed citations

16.

Greenwald, David, Daniel M. Moreira, Rongwen Tain, et al.. (2018). Constructing and Pilot Testing a Novel Prostate Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Phantom. Urology. 124. 33–37. 4 indexed citations

17.

Malhotra, Neha, et al.. (2017). Biliary Stent Migration: A Rare Cause of a Bladder Stone. Urology. 104. e1–e2. 1 indexed citations

18.

Hoskins, Kent, et al.. (2017). Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer – a SEER analysis. BMC Cancer. 17(1). 659–659. 4 indexed citations

19.

Terris, Martha K., William J. Aronson, Christopher J. Kane, et al.. (2015). Agent Orange and long-term outcomes after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 33(7). 329.e1–329.e6. 5 indexed citations

20.

Abern, Michael R., Ajay Gopalakrishna, Richmond Owusu, et al.. (2015). Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. Urologic Oncology Seminars and Original Investigations. 33(9). 387.e1–387.e6. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact